6 funding opportunities found in this category. 

World Federation of Hemophilia Clinical Research Grant Program
World Federation of Hemophilia
All Regions
08/31/2013
$100,000

World Federation of Hemophilia Clinical Research Grant Program

The WFH is pleased to launch its new Clinical Research Grant Program to provide support for international clinical investigation relating to inherited bleeding disorders.

The aim is to help create better evidence for the clinical management of hemophilia A and B, von Willebrand disease, rare factor deficiencies, and inherited platelet disorders. The program is peer reviewed and is open to researchers globally.

The WFH Clinical Research Grant Program will award up to four grants (two in each category) per year for the best proposals that address critical clinical issues of broad international significance.

Grant amount/duration

There are two levels of funding available:

• $10,000-$15,000 per year

• $35,000-$50,000 per year

Funding is awarded for up to two years.

An initial one-page letter of intent and a one-page CV is submitted in English. Completed forms must be sent by email to crgp_applications@wfh.org by August 31, 2013. Applications are peer reviewed by the Grant Review Committee. Successful candidates are shortlisted.

Shortlisted candidates will be notified and asked to submit a full proposal (maximum five pages) in English by December 1, 2013.

For more information, contact crgp@wfh.org.

Physician Researcher, Hematologist
Histiocytosis Association 2013 Request for Research Proposals
Histiocytosis Association
All Regions
07/31/2013
$50,000

Histiocytosis Association 2013 Request for Research Proposals

Conquering the Histiocytic Disorders

The Histiocytosis Association funded more than $300,000 in scientific research in 2012. 

Application for 2013 funding will be accepted online from May 15 to July 31, 2013.

Grant Award Amount: up to $50,000 USD each

Grant Award Date: December 2013

A Rare Community

The Histiocytosis Association is a global nonprofit organization dedicated to addressing the unique needs of
patients and families dealing with the effects of histiocytic disorders while leading the search for a cure. It is the
only organization of its kind, connecting the patient and medical communities to:

• Grow and share knowledge of histiocytic disorders,

• Provide critical emotional and educational support to patients and families, and

• Identify and fund key research initiatives that will lead to a world free of histiocytic disorders.

Funding the Path to a Cure

Proposals for scientific research are being accepted for studies into the causes, mechanisms, and improved
means of treatment for histiocytic disorders. Proposals will be evaluated on the basis of science, feasibility, and
relevance. All proposals should address one or more of the histiocytic disorders; below are areas of particular
interest; however, all relevant areas of interest will be considered.

• Mechanisms of disease pathogenesis

• Biology (maturation, migration and immune function) of dendritic cells, macrophages and/or

• lymphocytes in disease pathogenesis

• Derangements of cytokine production or function

• CNS pathology

• Neuropsychiatric consequences

• Studies of rare forms -- Juvenile xanthogranuloma, Erdheim-Chester disease, Rosai-Dorfman disease

•Studies of histiocytic disorders in adults

• Discovery of new disease markers

• Startup support for pilot studies/clinical trials

Research Grant Applications will be reviewed and evaluated by the Histiocyte Society Scientific Committee for relevance, scientific impact and feasibility. The Histiocytosis Association receives the composite score from this review, and the grant applications are then ranked for funding based upon programmatic needs and the availability of funds in each grant application cycle.

For questions regarding Research grants, please contact grants@histio.org.

Physician Researcher, Oncologist, Hematologist
Children’s Leukemia Research Association Research Grant Program
Children’s Leukemia Research Association
All Regions
06/30/2013
$30,000

Children’s Leukemia Research Association Research Grant Program

Each year, CLRA's Medical Advisory Committee, consisting of prominent internationally known and respected hematologists, reviews submitted research proposals from doctors nationwide. 

Using your contributions, we fund research grants for doctors who are conducting the most promising research into leukemia, in the hopes of isolating the causes and finding a cure for this dread disease.

The objectives of this committee are to direct the funds of the Association into the most promising projects, and where funding would not duplicate other funding sources.

With your help, we are getting closer every day! Because of the support of friends like you, the scientific community is making incredible strides in developing chemotherapy regimens that are extending the lives of leukemia patients. Not everyone under treatment goes into remission but our research grants are funding the examinations into why this is so, and how we can continue to combat leukemia.

How the CLRA Research Grant Program Works

Any doctor at the Ph.D. or MD level who is involved in research towards finding the causes and cure for leukemia may apply.

Simply complete online form and print, or call or write to us for one.

Please submit an original and three copies of your application prior to June 30 of each year.  It is then reviewed by our Medical Advisory Committee. A decision is made by the following calendar year.

In order that we may fund as many projects as possible, grants are limited to a maximum of $30,000 each, subject to availability of funds.

CLRA
585 Stewart Avenue
Suite 18
Garden City, NY 11530

Tel:  516-222-1944
Fax: 516-222-0457

info@childrensleukemia.org

Physician Researcher, Oncologist, Hematologist
Call for Applications: Alex’s Lemonade Stand Foundation Bridge & Springboard Grants
Alex’s Lemonade Stand Foundation
All Regions
06/21/2013
$100,000

Call for Applications: Alex’s Lemonade Stand Foundation Bridge & Springboard Grants

Bridge Grant

Alex’s Lemonade Stand Foundation introduces a new funding opportunity for researchers whose projects are in jeopardy due to the decreased funding available from the National Institutes of Health (NIH). ALSF’s Bridge Grants are intended to keep scientist’s projects on track while they reapply for NIH funding to ensure novel childhood cancer research projects are not compromised. ALSF’s Bridge Grant awards will provide $100,000 for 12 months to be used for supplies, personnel or the Principal Investigator’s salary.

Eligibility Requirements:

Project must have been previously funded by an NIH R01, R03, R21 or P01 Award. (R01 Supplements are not eligible for Bridge Grants.)

Researchers must have applied to the NIH for an R01 or P01 renewal for an ongoing project or to continue the project via new R01 or P01 within the last 6 months.

The application must have been scored ≤25th percentile, but outside of the agency’s fundable range.

Applicants must be reapplying for an R01 or P01 Award from the NIH within the next two NIH Grant cycles.

Projects must be aligned with ALSF’s mission, thus focused on better diagnosing or curing childhood cancers.

Funds may be used for supplies, personnel or PI’s salary and may not exceed $100,000. ALSF does not pay indirect costs. 
  
Application Process:

To expedite the application progress, ALSF’s Scientific Advisory Board will review the previously reviewed NIH application along with any changes that have been made in response to feedback from NIH reviews.

A cover letter, summary statement, response to NIH critique and budget will be required by all applicants.

All applications must be submitted via ALSF’s online application.
    
Springboard Grant

ALSF’s offers the Springboard Grant in response to cut-backs in National Institutes of Health (NIH) funding of new R01 and P01 applications. The Springboard Grant is designed to jump-start new projects with high impact potential for childhood cancer research while other funding is sought. Awards will provide $100,000 for 12 months to be used for supplies, personnel or the Principal Investigator’s salary.

Eligibility Requirements:

Researchers must have applied to the NIH for an R01 or P01 award within the last 6 months. (R01 Supplements are not eligible for Springboard Grants)

Applications must have scored ≤20%, but outside of the agency’s fundable range.

Applicants must be reapplying for an R01 or P01 award from the NIH within the next two NIH Grant cycles.

Projects must be aligned with ALSF’s mission thus focused on better diagnosing or curing childhood cancers.

Funds may be used for supplies, personnel or PI’s salary and may not exceed $100,000. ALSF does not pay indirect costs. 

Application Process:

To expedite the application progress, ALSF’s Scientific Advisory Board will review the previously reviewed NIH application along with any changes that have been made in response to feedback from NIH reviews.

A cover letter, summary statement, response to NIH critique and budget will be required by all applicants.
All applications must be submitted via ALSF’s online application.

Alex's Lemonade Stand Foundation for Childhood Cancer  333 E. Lancaster Ave., #414 Wynnewood, PA 19096

Ph: 610.649.3034

Fax: 610.649.3038

Physician Researcher, Oncologist, Hematologist
Request for Application: Cutaneous Lymphoma Foundation’s CLARIONS Research Awards Program
Cutaneous Lymphoma Foundation
All Regions
07/31/2013
$25,000

Request for Application: Cutaneous Lymphoma Foundation’s CLARIONS Research Awards Program

The signature funding initiative of the Research Awards Program (RAP), is the CLARIONS Grant Program, which stands for Curing Cutaneous Lymphoma by Advancing Research, Innovation and Offering New Solutions.  This research grant program supports investigators interested in conducting innovative cutaneous lymphoma research.   These grants will help uncover causes and improve the treatment and quality of life for patients. Discovering new avenues for better therapies and, one day, a cure for cutaneous lymphoma are key goals of this program.

Research Funding Priorities

Eligibility and Requirements

Investigators at all levels, from clinical and post-doctoral fellows to established investigators, are eligible to receive
awards. Medical students and graduate students are not eligible. Non-U.S. investigators are eligible and the research funded by the RAP can be conducted at non-U.S. institutions. Investigators must be members of an established and recognized academic institution. All research projects involving human subjects must receive IRB approval.

Award Amounts

Each year the CLF will provide two $25,000 awards, renewable for 1 year contingent upon approval by the CLF
Board of Directors based upon the CLF Scientific Review Board’s review and recommendation.

A small indirect cost amount between $1,000-$2,000 is allowable.

The CLF’s RAP seeks to fund innovative research in all areas of cutaneous lymphomas with particular interest in:

-- Etiology and risk factors of cutaneous lymphomas.

-- Measures of disease impact on individuals and populations affected by cutaneous lymphomas.

-- Translating discoveries into diagnostic and therapeutic advances in cutaneous lymphomas.

-- Optimizing therapies for cutaneous lymphomas.

-- Improving quality of life for individuals with cutaneous lymphomas

2013 Calendar of Award Events

January 31 -  Public announcement of Request for Application (RFA)

July 31 -  Application deadline

August - October - Scientific Review Board review

November - Recipients notified of award

December - Grant awards announced at ASH meeting

January, 2014 - Disbursement of Award and beginning of new award cycle

Cutaneous Lymphoma Foundation
PO Box 374
Birmingham, MI 48012-0374

Telephone: 248-644-9014

Fax: 248-644-9014

Junior Scientist, Young Scientist, Junior Faculty, Physician Researcher, Junior Researcher, Junior Investigator, Young Investigator, New Investigator, Established Investigator, Hematologist, New Researcher, Postdoctoral Fellow
American Society of Hematology Physician-Scientist Career Development Award
American Society of Hematology
All Regions
09/01/2013
$42,000

American Society of Hematology Physician-Scientist Career Development Award

ASH developed the Physician-Scientist Career Development Award to immerse medical students between their first and second or second and third years of school in a one-year, full-time research experience in hematology.

Under the mentorship of outstanding faculty, medical student recipients of the ASH Physician-Scientist Career Development Award will experience in-depth exposure to hematology, thereby enhancing the likelihood that the funded students will ultimately pursue a career in hematology.

Award Amount
The award is for a one-year period, generally July 1 through June 30. Up to five awards will be awarded per year.

The total amount of the award is $42,000. The award is comprised of $28,000 to support the trainee, a $5,500 research allowance for supplies, $5,500 for insurance and educational expenses (including one course), and $3,000 for meeting attendance.

Awards will be paid directly to the participating institution of the mentor, not to the mentor or the recipient. Indirect costs (i.e., facilities and administration costs) are not allowed.

Timeline

September 1, 2013 Application Due

November 2013 Award Notification

July 1, 2014 Award Activation

Eligibility

Eligible applicants must:

•Submit a complete application.

•Be a first or second year medical student actively enrolled in a US or Canadian LCME or AOA COCA accredited medical school, and be in good standing relative to their course work, at the time of application.

•Be between their 1st and 2nd or 2nd and 3rd year of medical school at the time the research is done.

•Not be currently enrolled in a combined MD-PhD program. Students who earned a PhD prior to medical school will be considered on an individual basis if the field of PhD study lies outside of biomedical science.

•Be planning an investigative career in laboratory, translational, or clinical hematology research.

•Propose a project that may take place at the institution where the applicant is in medical school or at another institution with sufficient activity in hematology research and education as judged by the award study section.

•Propose a research project in hematology which will be exclusive to the applicant and will be conducted within the mentor’s lab.

•Have a research mentor who is an active ASH member at the time of application and remains a member for the duration of the award period. The mentor will oversee the progress and work of the award recipient, will assist in completing the program application, aid the recipient in their research, and ensure that the recipient meets all deadlines, including those for award reports. The mentor must have active research funding in hematology from NIH or an equivalent organization.

•Propose a research mentor who is a member of ASH in good standing at the time of Letter of Intent submission, and for the duration of the award period.

•Not have any other concurrent funding for a similar experience.

•Agree to spend more than 80% of his/her time conducting research during the one-year experience. Some clinical shadowing of hematologists or related providers during the year is allowed.

•Plan to conduct the research at an institution that will allow for continued enrollment in medical school and/or will provide an alternative mechanism for the student to maintain health, dental, and vision insurance during the award time period (up to $5,500 in funding is provided for premiums for this insurance).

No more than one award will be made to a student working with one mentor.

Additional Mentoring

ASH believes a multiple mentorship model is important for researchers regardless of their career stage. Therefore, the applicant may include a second mentor in his/her application to provide advice and support principally about career development but also for research questions. If the study section believes a second mentor is needed but the application does not include a second mentor, members of the study section will be responsible for identifying an appropriate mentor and facilitating contact.The additional mentor will coordinate with the research mentor to the extent that is feasible and desirable.

Application Process

•Applications MUST be submitted electronically to training@hematology.org by 11:59 pm, Eastern, September 1, 2013.

•Only electronic submissions will be accepted.

•The file should be named in the following format: Physician-Scientist Career Development Award Last name-First name Application 2014.pdf

•Only ONE submission will be accepted. No updates, revisions, changes, or additions will be accepted or considered.

•All submissions MUST include the required documents listed below, in the order below, and be submitted as one PDF file to be accepted or considered.

◦Complete Physician-Scientist Career Development Award Application Form

◦Project proposal (3 page limit, including figures, at 12 point font with .5 inch margins), and references (1 page limit at 12 point font with .5 inch margins)

◦Applicant career development plan (1 page limit at 12 point font with .5 inch margins)

◦Applicant Biosketch - Standard NIH format (4 page limit)

◦Mentor Letter of Support stating the support the applicant will receive from the mentor and the mentor’s institution (2 page limit at 12 point font with .5 inch margins).

◦Mentor Biosketch - Standard NIH format (4 page limit)

◦Institutional Letter of Support from a dean of the home institution of the applicant, or an appropriate leader of the institute where the research will be conducted, confirming that if accepted the applicant will continue to be enrolled in medical school and/or insurance will be maintained during the award period (1 page at 12 point font with .5 inch margins).

An email from ASH will be sent to the applicant within one business day of receiving the application to confirm receipt. If an email is not received, the applicant should notify ASH staff immediately. Failure to notify ASH could result in the application not being reviewed.

Any submission that does not follow the application requirements, is not formatted correctly, is lacking information, has incorrect information, or is lacking required documents will be deemed ineligible and will not be reviewed by the study section. There will be no appeals or consideration for additional or further review once an application has been determined to be ineligible.

ASH Annual Meeting Event

Award recipients must attend the ASH annual meeting and attend an orientation breakfast. During the breakfast, members of the Committee on Training Programs and the Trainee Council will be available to discuss specific areas of research as well as give award recipients advice on specific meetings, sessions, abstracts, or posters at the annual meeting which may be related to their area of interest.

Review Criteria

Criteria for review of the applications will include:

•The significance and originality of the proposed study and hypothesis.

•The appropriateness, feasibility, and adequacy of the proposed experiment and methodology.

•A focus on hematology basic, translational, or health sciences research.

•The qualifications and experiences of the applicant. Factors to be considered include, among others, the potential for future independent investigation and commitment to a career in hematology research.

•The qualifications of the mentor both in terms of past mentorship in hematology and also ability to lead the medical student to a successful end product of a submitted manuscript within the year of research work.

•The strength of the institutional letter of support as it pertains to the quality and level of support the applicant is to receive from the institution.

Award Terms

•The award is for a one-year period, July 1 through June 30 (off cycle exceptions can be allowed with explanation).

•For recipients with two year projects, an interim progress report is required at the half way point.

•Up to five awards will be awarded per year.

•The total award amount $42,000. The award is comprised of $28,000 to support the trainee, a $5,500 for research allowance for supplies, $5,500 for insurance and educational expenses (including one course), and $3,000 to for meeting attendance.

•Award recipients are required to attend the ASH annual meeting and attend the orientation breakfast. Funds to attend the ASH meeting will be paid from the funds allotted for meeting attendance.

•Payments are made to the institution at which the recipient will conduct his/her research in two equal installments first on July 1 and then on January 1.

•Depending upon curriculum requirements, it is the decision of each medical school as to whether or not the award recipient continues to be enrolled in medical school during the award period.

•Recipients must be conducting research at an institution that will allow for continued enrollment in medical school and/or alternative mechanism for the student to maintain health, dental, and vision insurance during the award time period (up to $5,500 in funding is provided for insurance premiums for and educational expenses).

•Recipients are to arrange for their own health insurance either through their institution or independently.

•Award recipients are expected to attend the ASH annual meeting and attend the orientation breakfast.

•At the conclusion of the award period, a final report is required highlighting the project’s progress and summarizing the usage of funds.

•All recipients must agree to provide a permanent email address.

•A record of award recipients will be kept and the contact information updated for at least 10 years after the award period.

•Following the award period, recipients are required to respond to all requests from the Society for information on their career progress as outlined in the Final Report and Monitoring section.

•Award funds cannot be deferred and are non-transferable.

•No-cost extensions may be requested by a recipient if needed. The letter will need to be submitted by the mentor in writing to the Committee on Training Programs Awards Subcommittee chair asking for a no-cost extension. It will be at the discretion of the Committee on Training Programs Awards Subcommittee and the study section chair to approve of the request. Any requests should be mailed to ASH with attention to the Training Department or emailed to training@hematology.org.

•For recipients granted a renewal, an interim progress report is required at the half way point.

•Receipt of the Physician-Scientist Career Development Award does not include or require an ASH Annual Meeting abstract submission.

•If selected for an award, the trainee will agree to cite support from the “American Society of Hematology (ASH)” in any publication or poster describing research conducted during the award period.

•Any visa and citizenship restrictions applicable to receiving Physician-Scientist Career Development Award are the responsibility of the applicant.

•All funds must be used to provide the award recipient a stipend and any supplies for the purposes of conducting the research submitted in the application. Indirect costs (i.e. facilities and administration costs) are not allowed for any Physician-Scientist Career Development Award. Violation will result in the revocation of the award funds.

•All ASH funding not spent by the end of the award term must be returned to the Society within ninety (90) days of submitting the final report. A check made out to the American Society of Hematology must be sent to the attention of the Training Manager at ASH Headquarters.

Additional Year Reapplication

Students making significant progress may submit a written request to renew the award for one additional year. Award renewal requests should be submitted at 9 months into the award period.These requests will be judged competitively against new award applications and on a case by case basis by considering the progress made during the first year of research.

Final Report Monitoring

ASH Physician-Scientist Career Development Award recipients are required to submit a final written report (not to exceed 4 pages).This will include a summary of research, manuscript submissions during the award period related to the funded research, presentations (locally and nationally) of the funded research during the award period, and educational goals met. This report must be sent to ASH Headquarters to the attention of the Training Manager. Members of the ASH Training Awards Subcommittee will evaluate final reports.

For recipients with two year projects an interim progress report is required at the half way point.

Failure to submit the final report, or an interim progress report, will render the applicant ineligible for future ASH funding.

Following the award period, recipients are required to respond to all requests from the Society for information on their career progress.

Questions?

If you have any questions or require any additional information regarding the Physician-Scientist Career Development Award, please contact training@hematology.org.

Medical Student